544 related articles for article (PubMed ID: 16766046)
1. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
Saurer TB; Ijames SG; Lysle DT
J Neuroimmunol; 2006 Aug; 177(1-2):18-26. PubMed ID: 16766046
[TBL] [Abstract][Full Text] [Related]
2. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell.
Saurer TB; Carrigan KA; Ijames SG; Lysle DT
J Neuroimmunol; 2006 Apr; 173(1-2):3-11. PubMed ID: 16364456
[TBL] [Abstract][Full Text] [Related]
3. Alterations of immune status induced by the sympathetic nervous system: immunomodulatory effects of DMPP alone and in combination with morphine.
Fecho K; Maslonek KA; Dykstra LA; Lysle DT
Brain Behav Immun; 1993 Sep; 7(3):253-70. PubMed ID: 8219413
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
[TBL] [Abstract][Full Text] [Related]
5. Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
Saurer TB; Ijames SG; Carrigan KA; Lysle DT
Brain Behav Immun; 2008 Jan; 22(1):89-97. PubMed ID: 17689049
[TBL] [Abstract][Full Text] [Related]
6. Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats.
Fecho K; Maslonek KA; Dykstra LA; Lysle DT
J Pharmacol Exp Ther; 1996 May; 277(2):633-45. PubMed ID: 8627540
[TBL] [Abstract][Full Text] [Related]
7. Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates.
Upadhya MA; Dandekar MP; Kokare DM; Singru PS; Subhedar NK
Neuropeptides; 2009 Aug; 43(4):303-14. PubMed ID: 19556004
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status.
Lysle DT; Hoffman KE; Dykstra LA
J Pharmacol Exp Ther; 1996 Jun; 277(3):1533-40. PubMed ID: 8667220
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats.
Fecho K; Maslonek KA; Dykstra LA; Lysle DT
J Pharmacol Exp Ther; 1996 Feb; 276(2):626-36. PubMed ID: 8632330
[TBL] [Abstract][Full Text] [Related]
10. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
11. NPY mediates reward activity of morphine, via NPY Y1 receptors, in the nucleus accumbens shell.
Desai SJ; Upadhya MA; Subhedar NK; Kokare DM
Behav Brain Res; 2013 Jun; 247():79-91. PubMed ID: 23511250
[TBL] [Abstract][Full Text] [Related]
12. Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity.
Carr DJ; Gebhardt BM; Paul D
J Pharmacol Exp Ther; 1993 Mar; 264(3):1179-86. PubMed ID: 8383741
[TBL] [Abstract][Full Text] [Related]
13. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity.
Freier DO; Fuchs BA
J Pharmacol Exp Ther; 1994 Sep; 270(3):1127-33. PubMed ID: 7932161
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholinesterase monoclonal antibody-induced sympathectomy: effects on immune status and acute morphine-induced immunomodulation.
Fecho K; Maslonek KA; Dykstra LA; Lysle DT
Brain Behav Immun; 1997 Sep; 11(3):167-84. PubMed ID: 9417803
[TBL] [Abstract][Full Text] [Related]
15. The role of dopaminergic systems in opioid receptor desensitization in nucleus accumbens and caudate putamen of rat after chronic morphine treatment.
Noble F; Cox BM
J Pharmacol Exp Ther; 1997 Nov; 283(2):557-65. PubMed ID: 9353370
[TBL] [Abstract][Full Text] [Related]
16. Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease.
Rangani RJ; Upadhya MA; Nakhate KT; Kokare DM; Subhedar NK
Peptides; 2012 Feb; 33(2):317-28. PubMed ID: 22266216
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic analysis of splenocyte subsets following acute morphine treatment in the rat.
Fecho K; Lysle DT
Cell Immunol; 1999 Aug; 195(2):137-46. PubMed ID: 10448013
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
Rouillon C; Abraini JH; David HN
Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
[TBL] [Abstract][Full Text] [Related]
19. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats.
Taksande BG; Kotagale NR; Gawande DY; Bharne AP; Chopde CT; Kokare DM
Eur Neuropsychopharmacol; 2014 Jun; 24(6):955-63. PubMed ID: 24461723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
